ADVANCE infectious diseases pharmacy and LEAD antimicrobial stewardship in order
to OPTIMIZE the care of patients

Featured News

  • 14 Feb 2017 10:00 AM | David Ha (Administrator)

     

    Washington, D.C. – The Board of Pharmacy Specialties (BPS) is pleased to announce the approval of two new specialties; cardiology pharmacy and infectious diseases pharmacy. This announcement follows the final review of the petitions for each new specialty that took place during the BPS Board meeting held on February 8, 2017.

    Harold Godwin, the 2017 Chairman of the BPS Board of Directors and Professor Emeritus at the University of Kansas School of Pharmacy provided the following comments: “The Board of Pharmacy Specialties is very pleased to formally acknowledge two new pharmacy specialties. The recognition of these specialties further illustrates our growth as           a clinical profession and our ever increasing responsibilities in providing patient care. I want to also acknowledge the collaborative efforts of the four national pharmacy associations that developed these petitions. That type of collaboration is critical to the continued success of the pharmacy profession.”

    Cardiology Pharmacy

    Cardiology pharmacy becomes the tenth BPS specialty. The petition was submitted jointly by the American College of Clinical Pharmacy, American Pharmacists Association and the American Society of Health-System Pharmacists.

    The petitioning organizations have defined Cardiology Pharmacy practice as follows:

    Cardiology Pharmacy practice specializes in the delivery of direct patient care services by pharmacists as members of interprofessional healthcare teams, working to ensure the safe and effective use of medications in patients with cardiovascular disease. These specialists focus on disease prevention and treatment, including evidence-based medication use and related care that improve both short- and long-term outcomes for patients. Cardiology specialists practice across the spectrum of care, including ambulatory, acute and intensive care. Pharmacists in this practice review, analyze and monitor multifaceted clinical information to make reasoned decisions for patients with multiple comorbidities and highly complex mediation regimens.

    Infectious Diseases Pharmacy

    Infectious diseases pharmacy becomes the eleventh BPS specialty. The petition was submitted jointly by the American College of Clinical Pharmacy, American Pharmacists Association, American Society of Health-System Pharmacists and the Society of Infectious Diseases Pharmacists.

    The petitioning organizations have defined Infectious Diseases Pharmacy practice as follows:

    Infectious Diseases Pharmacy practice specializes in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate the pharmacodynamics and pharmacokinetics of antimicrobials to optimize therapy for patients. The practice requires pharmacists to use clinical and evidence-driven knowledge to develop appropriate antimicrobial therapies to more rapidly resolve infections while decreasing adverse events, complications and resistance. The practice includes direct patient care provided through interprofessional health care teams, collaborative leadership of antimicrobial stewardship programs, education of health care providers, preventive services including immunizations, and advocacy for appropriate antimicrobial utilization.

    Specialty pharmacy practice in infectious diseases uniquely improves public health by optimizing antimicrobial potential in individual patients and narrowing the resistance trends that occur in society by preventing progression of antimicrobial resistance and infectious diseases.


    Next Steps

    The next steps in the specialty certification process are outlined below:

    ·         BPS will issue a call during the first week of March 2017 for nominations to serve on the Cardiology and Infectious Diseases Pharmacy Specialty Councils. The closing date for nominations will be May 1, 2017.

    ·         BPS will appoint nine members to each Council by June 2, 2017.

    ·         The Councils will convene, on dates to be determined, in July 2017.

    ·         Examination item writing for the new specialties will begin during the third quarter of 2017 with a goal of offering the first examination in September 2018.

    Added Qualifications Program

    The BPS Board will re-evaluate the current Added Qualifications program. However, the Board anticipates that the Added Qualifications program for Cardiology and Infectious Diseases will end as of December 31, 2017 based upon the plan to offer the first examinations in those specialties in 2018. Individuals currently holding Added Qualifications can keep those credentials until they expire but will not be able to renew them. The National Commission for Certifying Agencies (NCCA) standards prohibit BPS from conferring Board Certification to those who hold Added Qualifications in either Cardiology or Infectious Diseases without passing the respective certification examination.

    William Ellis, BPS Executive Director added, “The growth of BPS and the addition of new specialties reflects the growth and maturation of the pharmacy profession. BPS is committed to being responsive and flexible in evaluating possible specialties that will improve patient care through recognition and promotion of specialized training, knowledge, and skills in pharmacy through the specialty board certification of pharmacists.”

    Eleven specialties are currently recognized by BPS including: (1) Nuclear Pharmacy, since 1978; (2) Nutrition Support Pharmacy, since 1988; (3) Pharmacotherapy, since 1988; (4) Psychiatric Pharmacy, since 1992; (5) Oncology

    Pharmacy, since 1996; (6) Ambulatory Care Pharmacy, since 2009; (7) Critical Care Pharmacy, since 2013; (8)

    Pediatric Pharmacy, since 2013; (9) Geriatric Pharmacy in 2017 (through CCGP); (10) Cardiology Pharmacy in 2017; and (11) Infectious Diseases Pharmacy in 2017. BPS certification exams are administered at over 500 locations worldwide, the Spring testing window application deadline is March 6, 2017 and the Fall 2017 registration will be open from May 8, 2017 until August 1, 2017. Candidates can register by going to the BPS website at  www.bpsweb.org.

    About the Board of Pharmacy Specialties

    The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world.

    Board Certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels as a result of the rigorous standards mandated by BPS board certification and recertification. Today over 30,000 pharmacists worldwide hold BPS certification.

    ###

    BPS CONTACT

    Ernest Wright ewright@aphanet.org 202-429-7510

    www.bpsweb.org


  • 05 Jan 2017 11:45 AM | Anonymous

    Completed 2017 YOUNG INVESTIGATOR PILOT AWARD APPLICATIONS (click here) are due by 5pm PDT on February 17, 2017. Applications should be submitted as pdf documents to CODCC@acsr.ucsf.edu

     

    The ACSR Young Investigator Pilot Award (YIPA) is targeted toward junior investigators and faculty with innovative ideas for translational, clinical and/or behavioral-epidemiological HIV-related research that utilizes ACSR’s annotated biospecimens collected from HIV/AIDS patients and controls from both pre and post-HAART periods. Awards are intended for pilot studies to show feasibility and/or to generate preliminary data that will support efforts to procure future funding of larger research projects.


  • 16 Dec 2016 9:48 AM | David Ha (Administrator)

    The ACSR Young Investigator Pilot Award (YIPA) is targeted toward junior investigators and faculty with innovative ideas for translational, clinical and/or behavioral-epidemiological HIV-related research that utilizes ACSR’s annotated biospecimens collected from HIV/AIDS patients and controls from both pre and post-HAART periods. Awards are intended for pilot studies to show feasibility and/or to generate preliminary data that will support efforts to procure future funding of larger research projects.

    Click here to learn more: https://acsr.ucsf.edu/?page_id=912/

  • 11 Nov 2016 11:52 AM | Anonymous

    Society of Infectious Diseases Pharmacists

    Call for Grant Applications to Fund

    Infectious Diseases Pharmacotherapy Residency

    The Board of Directors of the Society of Infectious Diseases Pharmacists (SIDP) is pleased to announce the availability of funding for an Infectious Diseases Pharmacotherapy Residency for the period of July 2017 through June 2018. This residency award will be partially funded by Allergan Inc. 

    Applications should be uploaded to the online resident award application form.  The RPD cover letter, letters of support (2) and curriculum vitas (up to 4) should be converted to a single PDF file and uploaded. Other information will be directly inserted on the web form.  Questions regarding submission may be submitted to Secretary/Treasurer Brandon Bookstaver (bookstaver@sccp.sc.edu). Proposals must be submitted no later than 5 PM E.D.T. on December 14, 2016. Applications submitted after this deadline will not be considered.  The Board of Directors will make decisions on the applications no later than January 6, 2017

    Click HERE for more details.


  • 06 Oct 2016 12:27 PM | Anonymous
    • Every year in the U.S., pneumococcal disease kills thousands of adults, and many more end up hospitalized, yet vaccination rates lag behind public health standards. Pharmacists are in a strong position to ensure that those adults of highest need receive timely vaccination according to the most recent national recommendations.

      This CPE webinar will provide you with strategies for improving vaccination rates in eligible patients and underserved populations, as well as tactics for overcoming common barriers to improve outcomes and reduce the high burden of this disease on the health system. Expert faculty will present case scenarios and answer your questions during the live Q&A.

      Register now at www.ProCE.com/Pneumo

    • 27 Oct 2016

    • 02 Nov 2016

    • Schedule

      2 sessions

    • Location

      Live Webcast


  • 05 Oct 2016 10:21 AM | George Allen

    SIDP has collaborated with the CDC and the PEW Charitable Trusts to develop the new "Joint Statement on Importance of Outpatient Antibiotic Stewardship from 12 National Health Organizations." The document may be found here:

    https://www.cdc.gov/getsmart/community/pdfs/joint-statement-on-importance-of-outpatient-antibiotic-stewardship-with-logos.pdf

    https://www.cdc.gov/getsmart/community/partners/joint-statement.html

  • 21 Sep 2016 3:04 PM | Anonymous

    Pharmacy Times® and the Society of Infectious Diseases Pharmacists (SIDP) have established a strategic partnership to provide antimicrobial expertise and infectious disease education to pharmacists.  Please click on the link below for full details:

    http://www.prweb.com/releases/PharmacyTimes/SIDPPartner/prweb13698410.htm

  • 08 Jul 2016 10:08 AM | George Allen

    SIDP is helping the U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) to develop and publish a collection of stories by people and families directly impacted by antibiotic resistant infections. SIDP is seeking patients or family members who have experienced a resistant infection (e.g., MRSA, CRE), who are willing to share their story. These stories are critical to help us demonstrate to policymakers the human cost of and urgent need for efforts to combat antimicrobial resistance to protect patients and public health.

    Antibiotic resistant bacteria are responsible for at least 23,000 deaths and at least 2 million infections each year, and cost the healthcare system approximately $20 billion. They also complicate many areas of medicine, including the care of preterm infants, chemotherapy, organ and bone marrow transplants, and other surgeries. 

    If you or someone you know (loved ones, colleagues, patients) have suffered from an antimicrobial resistant infection and are willing to share their story for this effort, please contact Emily Heil, Chair of the Political Advocacy Committee, at eheil@rx.umaryland.edu.


  • 29 Jun 2016 10:49 AM | David Ha (Administrator)

     

    SIDP and ASHP Publish Position Statement on “The Essential Role of Pharmacists in Antimicrobial Stewardship”

    According to the World Health Organization, the rapid increase in antibiotic resistance combined with a decline in the development of new antibiotics is a global crisis. Antimicrobial stewardship is therefore critical, and an article published in the July 2016 edition of Infection Control and Hospital Epidemiology discusses the essential role pharmacists play in this stewardship in accordance with guidelines released by the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). The article was written on behalf of the Society of Infectious Diseases Pharmacists (SIDP) and the American Society of Health-System Pharmacists (ASHP), and has been endorsed by the Society for Healthcare Epidemiology of America (SHEA) and the American College of Clinical Pharmacy (ACCP).

    SIDP Political Advocacy Committee Chair Emily Heil notes “with the recent release of the new IDSA/SHEA Antibiotic Stewardship guidelines, this statement provides support for the essential role that pharmacists play in antimicrobial stewardship. We were pleased to partner with ASHP on this effort with the endorsement of ACCP and SHEA.”

    “This statement reiterates the importance that pharmacists have in the conduct of antimicrobial stewardship programs in concert with our infectious diseases physician colleagues,” said SIDP President Jason Gallagher. “Successful antimicrobial stewardship programs require a team approach, and pharmacists are key to their success.”

    Founded in 1990, the Society of Infectious Diseases Pharmacists (SIDP) is an association of pharmacists and allied healthcare professionals dedicated to promoting the appropriate use of antimicrobial agents. For more information, visit
    http://www.sidp.org.

    Contact:
    Stephanie Bulak, Associate Executive Director
    Society of Infectious Diseases Pharmacists
    Phone: (512) 328-8632
    info@sidp.org

Membership gives you more

  • Access exclusive opportunities
  • Connect with colleagues
  • Attend networking events

JOIN TODAY


Society of Infectious Diseases Pharmacists • 110 E. Schiller Street, Suite 230, Elmhurst, IL 60126
(331) 248-7888 sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software